VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Activity

24 hedge funds and large institutions have $4.09M invested in VistaGen Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
William Blair & Company
1
William Blair & Company
Illinois
$1.54M
2
Wells Fargo
2
Wells Fargo
California
$161K
3
VF
3
Virtu Financial
New York
$65K
4
LPL Financial
4
LPL Financial
California
$67K
5
DADC
5
D.A. Davidson & Co
Montana
$112K

Top Sellers

1
SFM
1
Sphera Funds Management
Israel
$0
2
PVI
2
Pura Vida Investments
New York
$0
3
FSA
3
Fort Sheridan Advisors
Illinois
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$13K
5
HighTower Advisors
5
HighTower Advisors
Illinois
$142K
Name Market Value Shares Shares
Change 		Shares
Change %
FSA
26
Fort Sheridan Advisors
Illinois
– – -15,000 Closed
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$0 200 +200 New
1
2